Company Analysis
Sign in

Propanc Biopharma, Inc. (PPCB)

Nasdaq: PPCB · Pharmaceutical Preparations · Camberwell, Victoria, AU · filing with the SEC since 2011
Full chart Alerts Compare
Grade4.0
◀ Past 2.5● Present 4.1▶ Future 5.0
7 est.
OverviewBusinessFinancialsGradeForecastSentimentOwnershipPeopleFilingsPatents Chart

Income statement, as filed

In US dollars (USD), as filed; per-share figures in US dollars; share counts. The fiscal year ends in June.
Income statement, by fiscal year, newest first
Fiscal yearFY 2026FY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingJun 30, 2026Jun 30, 2025Jun 30, 2024Jun 30, 2023Jun 30, 2022Jun 30, 2021Jun 30, 2020Jun 30, 2019Jun 30, 2018Jun 30, 2017
Report filedSep 25, 2026Sep 29, 2025Sep 30, 2024Sep 28, 2023Sep 28, 2022Sep 28, 2021Oct 1, 2020Oct 15, 2019Sep 17, 2018Sep 28, 2017
Cost of revenue·······28,06230,52128,992
Research and development625,477223,721248,102247,919256,052230,956179,987260,3351,825,728971,769
General and administrative670,607108,950r1,253,7971,499,8851,706,4521,553,0753,281,4642,326,3502,103,6844,739,431
Total operating expenses18,185,56957,278,1311,536,0491,776,6451,990,8701,812,1433,494,2602,614,7473,959,9335,740,192
Operating income-18,185,569-57,278,131-1,536,049-1,776,645-1,990,870-1,812,143-3,494,260-2,614,747-3,959,933-5,740,192
Interest expense430,539563,757665,841532,821568,798449,4571,748,3811,314,5392,789,1963,202,774
Interest and investment income161960365,61319463187685
Other income (expense), net-6,000·····-1,381,191-3,259,059-3,258,528-2,432,981
Total non-operating income (expense)-677,141-1,645,169-413,611-1,013,762-722,194-327,219-1,381,191···
Income before income taxes-18,862,710-58,923,300-1,949,660-2,790,407-2,713,064-2,139,362-4,875,451-5,758,369-7,039,155·
Income tax expense··-129,132-129,841-54,977-113,415-134,728-115,437-179,306-305,673
Net income including non-controlling interests·····-2,025,947-4,740,723···
Net income-18,862,710-58,923,300-1,820,528-2,660,566-2,658,087-2,025,947r-4,740,723-5,758,369-7,039,155-7,867,500
Preferred dividends932,246·192,960466,273700,340391,749····
Net income to common shareholders-19,794,956-58,923,300-2,013,488-3,126,839-3,358,427-2,417,696-4,740,723···
Earnings per share, basic-17.62-371.22r-35,513.25rb-2,700,810.00b-73,867,153.50rb-1,200,360,000.00b····
Earnings per share, diluted-17.62-371.22r-35,513.25rb-2,700,810.00b-73,867,153.50b·····
Earnings per share, basic and diluted·····-1,200,360,000.00b-288,761,602,499.9999rb-16,459,936,500.00b-268,205,437,500.00rb-3,361,008,000.00b
Weighted average shares, basic1,123,709158,727r57rb1b68,219r3,032,612····
Weighted average shares, diluted1,123,709158,727r57rb1b0b·····
Weighted average shares, basic and diluted·····0b0rb0b0rb0b
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.Share counts and per-share figures are on the newest report's basis, after the 1-for-25 reverse split.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServicesSold
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
General and administrative the cost of running the company itselfus-gaap:GeneralAndAdministrativeExpense
Total operating expenses the running costs togetherus-gaap:OperatingExpenses
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
us-gaap:InterestExpense
Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther
us-gaap:InvestmentIncomeInterest
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Total non-operating income (expense) everything outside the business, togetherus-gaap:NonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income including non-controlling interests the whole group's profit, minority holders' share includedus-gaap:ProfitLoss
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Preferred dividends paid to preferred holders before common shareholdersus-gaap:PreferredStockDividendsIncomeStatementImpact
Net income to common shareholders what is left for common shareholdersus-gaap:NetIncomeLossAvailableToCommonStockholdersBasic
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Earnings per share, basic and diluted net income per share, where both counts are the sameus-gaap:EarningsPerShareBasicAndDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
Weighted average shares, basic and diluted the average count, where both counts are the sameus-gaap:WeightedAverageNumberOfShareOutstandingBasicAndDiluted
SI Assistanton PPCB · research, not advice